BioRestorative Therapies (BRTX) announced that the FDA has granted Fast Track designation to the BRTX-100 program for the treatment chronic lumbar disc disease.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
